ARTICLE | Clinical News
SU101: Discontinued Phase III trial
April 10, 2000 7:00 AM UTC
Pharmacia Corp. (PHA), Peapack, N.J. Product: SU101 Business: Cancer Therapeutic category: Signal transduction, Cell proliferation Target: PDGF receptor Description: Small molecule inhibitor of plate...